Disruptions in steroid metabolic pathways, commonly observed in HCC, often arise from altered enzymatic activity (such as cytochrome enzymes like CYP3A4) and dysregulation of steroid hormone receptors (including estrogen and androgen receptors) [32]. The gene discussed is AR; the disease is hepatocellular carcinoma.